We are live on ! Find out more
EC

Elequin Capital Portfolio holdings

AUM $1.19B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
-5.61%
1 Year Est. Return
+16.08%
3 Year Est. Return
+46.25%
5 Year Est. Return
10 Year Est. Return
AUM
$267M
AUM Growth
-$170M
Cap. Flow
-$43.3M
Cap. Flow %
-16.21%
Top 10 Hldgs %
79.28%
Holding
746
New
321
Increased
50
Reduced
153
Closed
192
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KAIR
201
DELISTED
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
$15K 0.01%
+1,500
New +$14.9K
MDH
202
DELISTED
MDH Acquisition Corp.
MDH
$15K 0.01%
+1,500
New +$14.8K
AKIC
203
DELISTED
Sports Ventures Acquisition Corp. Class A Ordinary Shares
AKIC
$15K 0.01%
+1,500
New +$14.9K
PSAG
204
DELISTED
Property Solutions Acquisition Corporation II Class A Common Stock
PSAG
$15K 0.01%
+1,564
New +$15.4K
EQHA
205
DELISTED
EQ Health Acquisition Corp.
EQHA
$15K 0.01%
+1,500
New +$14.8K
HLAH
206
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Class A Common Stock
HLAH
$15K 0.01%
+1,566
New +$15.4K
AXH
207
DELISTED
Industrial Human Capital, Inc.
AXH
$15K 0.01%
+1,500
New +$15.2K
DISH
208
DELISTED
DISH Network Corp.
DISH
$15K 0.01%
1,058
-1,804
-63% -$31.9K
MEOA
209
DELISTED
Minority Equality Opportunities Acquisition Inc. Class A Common Stock
MEOA
$15K 0.01%
+1,500
New +$15.2K
AES icon
210
AES
AES
$10.6B
$14K 0.01%
626
-592
-49% -$14K
GFL icon
211
GFL Environmental
GFL
$14.9B
$14K 0.01%
561
-700
-56% -$19.4K
NI icon
212
NiSource
NI
$21.6B
$14K 0.01%
556
-739
-57% -$21.8K
DALS
213
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
$14K 0.01%
+1,483
New +$14.4K
IQMD
214
DELISTED
Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD
$14K 0.01%
+1,400
New +$14.1K
GXII
215
DELISTED
GX Acquisition Corp. II Class A Common Stock
GXII
$14K 0.01%
+1,400
New +$13.7K
AMPX.WS icon
216
Amprius Technologies Warrants
AMPX.WS
$386M
$13K ﹤0.01%
+40,500
New +$15.3K
BKNG icon
217
Booking.com
BKNG
$150B
$13K ﹤0.01%
200
-250
-56% -$18.8K
CYTK icon
218
Cytokinetics
CYTK
$10.9B
$13K ﹤0.01%
+265
New +$12.8K
SEDG icon
219
SolarEdge
SEDG
$2.54B
$13K ﹤0.01%
55
-46
-46% -$13.6K
XAGE
220
DELISTED
Longevity Health Holdings, Inc. Common Stock
XAGE
$13K ﹤0.01%
+45
New +$13.1K
EOCW
221
DELISTED
Elliott Opportunity II Corp.
EOCW
$13K ﹤0.01%
+1,300
New +$12.7K
OSTR
222
DELISTED
Oyster Enterprises Acquisition Corp. Class A Common Stock
OSTR
$13K ﹤0.01%
+1,300
New +$12.8K
EXAS
223
DELISTED
Exact Sciences
EXAS
$12K ﹤0.01%
377
-224
-37% -$9.23K
MTCH icon
224
Match Group
MTCH
$9.17B
$12K ﹤0.01%
+245
New +$15.4K
P
225
Everpure Inc
P
$25B
$12K ﹤0.01%
424
-369
-47% -$10.4K

Similar funds

Elequin Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Elequin Capital held 746 positions worth $267M, down 39% from $437M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Elequin Capital withdrew a net $43.3M in Q3 2022, closing 192 positions and reducing 153 holdings. Its most notable exit was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A, an estimated $140M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 9.4% a quarter earlier, followed by Real Estate and Technology.

Against the trend, Elequin Capital opened a new position in Stanley Black & Decker, Inc. worth $41.1M.

  • Elequin Capital's largest Q3 2022 buy was Stanley Black & Decker, Inc.: 850,245 shares worth $41.1M.
  • Elequin Capital added most to South Jersey Industries, Inc. Corporate Units in Q3 2022, an estimated $21.4M increase.
  • Elequin Capital's biggest Q3 2022 reduction was Austerlitz Acquisition Corporation II, cutting an estimated $1.01M.
  • Elequin Capital fully exited Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A in Q3 2022, selling an estimated $140M.
  • Elequin Capital's ten largest holdings make up 79% of its $267M portfolio in Q3 2022.
  • Elequin Capital opened 321 new positions and closed 192 in Q3 2022.
  • Elequin Capital's portfolio value fell 39% quarter-over-quarter to $267M.

Based on Elequin Capital's 13F filing for Q3 2022, filed 10 Nov 2022.